Skip to main content

Table 1 Demographic and clinical characteristics of patients with idiopathic pulmonary fibrosis

From: Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry

 

N available

Total

Gender (male/female), n

608

491 (80.8)/ 117 (19.2)

Age, mean years (SD)

608

70.2 (9.2)

Weight mean kg (SD) a

549

77.0 (14.2)

Height mean cm (SD) b

547

165.0 (8.9)

Body mass index, Kg/m2 (SD) b

547

28.2 (4.2)

Smoking habits, n (%)

608

 

 Never-smoker

 

164 (27.3)

 Ex-smoker

 

382 (63.7)

 Smoker

 

54 (9.0)

Charlson comorbidity index, mean (SD) c

563

3.5 (1.7)

 Estimated 10-year survival, mean % (SD) d

607

59.8 (29.6)

Occupational exposure to, n (%)

608

 

 Inorganic particles

 

131 (23.2)

 Organic particles

 

120 (21.4)

 Potentially harmful aerosols

 

63 (11.3)

Family history, n (%)

608

 

 IPF

 

57 (9.7)

 Other DILD

 

23 (4.2)

Time from diagnosis to inclusion in the registry, mean years (SD)

608

1.7 (2.2)

Months from the onset of symptoms to diagnosis, mean (SD) e

547

20.4 (21.4)

Main comorbidities, n (%)

608

 

 Diabetes mellitus with no target organ damage

 

89 (15.8)

 Other chronic pulmonary disease

 

88 (15.6)

 Gastroesophageal reflux

 

74 (12.8)

 Pulmonary emphysema

 

70 (12.1)

 Coronary artery disease

 

50 (8.6)

 Myocardial infarction

 

46 (8.2)

 Pulmonary hypertension

 

36 (6.2)

 Malignancies

 

30 (5.3)

 Sleep apnoea-hypopnea syndrome

 

29 (5.0)

 Peripheral vascular disease

 

24 (4.3)

  1. SD standard deviation, IPF idiopathic pulmonary fibrosis, DILD diffuse interstitial lung disease. Calculated over: a 549 patients, b 547 patients, c 563 patients, d 607 patients, e 547 patients